Increasing evidence supports the role of TPX2 as a tumor promoter in human tumor development, with bladder cancer tissues expressing high TPX2 levels having upregulated p53 expression and downregulated GLIPR1 expression. The gene discussed is GLIPR1; the disease is urinary bladder cancer.